08:00 , Dec 10, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Toll-like receptor 9 (TLR9)

Cancer INDICATION: Pancreatic cancer Patient sample and mouse studies suggest TLR9 inhibitors could help treat pancreatic cancer. TLR9 levels were higher in tumor samples from patients with pancreatic ductal adenocarcinoma (PDAC) than in normal pancreatic tissue from...